Delivery Order SPE2DB22D3401-SPE2DB25FT4DM
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $35,435.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 9, 2025, for Zepbound 7.5 mg/0.5 mL pens. The contract, which carries an ultimate completion date of September 10, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $17,544.13 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This is a firm fixed price contract with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,287.74 delivery order to AmerisourceBergen Drug Corp on February 11, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is classified as firm fixed price with no set-aside designation, indicating it was awarded through open competition. Performance will be completed by February 12, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $8,205.18 firm fixed price delivery order for Zepbound 15 mg/0.5 mL pen injectors, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products to federal medical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,091.55 for Zepbound 5 mg/0.5 ml pens on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $30,943.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on September 11, 2025, with completion expected by September 12, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT4DMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The Zepbound delivery order represents a component of the company's broader pharmaceutical support mission under the DLA Troop Support Medical contract, which serves customers including the Defense Health Agency and U.S. Coast Guard. Performance of this delivery order will be executed at the contractor's Conshohocken facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 6/2/25 |